Related Experiment Video
Updated: Jun 12, 2026

A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
Published on: April 16, 2021
Pasteurella multocida thymidine kinase 1 efficiently activates pyrimidine nucleoside analogs
A R Clausen1, S A L Al Meani, J Piskur
1Department of Cell and Organism Biology, Lund University, Solvegatan, Lund, Sweden. Anders.Clausen@cob.lu.se
Researchers identified a Pasteurella multocida thymidine kinase 1 (PmTK1) gene. This gene activates nucleoside antibiotics, with deoxyuridine as its preferred substrate, offering potential for targeted therapies.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- The Pasteurella multocida genome contains a single gene encoding a putative deoxyribonucleoside kinase, identified as thymidine kinase 1 (PmTK1).
- Understanding the substrate specificity and enzymatic activity of PmTK1 is crucial for exploring its potential applications.
Purpose of the Study:
- To characterize the Pasteurella multocida thymidine kinase 1 (PmTK1) enzyme.
- To investigate the substrate specificity of PmTK1 and its potential as a drug target or activator.
Main Methods:
- Sub-cloning of the PmTK1 gene into Escherichia coli.
- Over-expression and purification of PmTK1 using two different affinity tags.
- Sensitization of E. coli to various nucleoside analogs, including gemcitabine (dFdC), AZT, and 5F-dU.
Main Results:
- The expressed PmTK1 sensitized E. coli to gemcitabine, AZT, and 5F-dU, indicating its kinase activity.
- Purified PmTK1 demonstrated a preference for deoxyuridine (dU) as a substrate over thymidine (dT).
Conclusions:
- Pasteurella multocida thymidine kinase 1 (PmTK1) is a functional deoxyribonucleoside kinase.
- PmTK1's substrate preference suggests its potential utility as a species-specific activator for uracil-based nucleoside antibiotics.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Biosynthesis of Nucleic Acids

